PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program
Value in Health · 2025-07 · 28 (6) · S61
DOI: 10.1016/j.jval.2025.04.291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2025-07. Verfasst von Mirko V. Sikirica und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sikirica, M. V., Rashid, N., Revankar, R., & Youakim, J. M. (2025). PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program. Value in Health, 28(6), S61. https://doi.org/10.1016/j.jval.2025.04.291
Vancouver
Sikirica MV, Rashid N, Revankar R, Youakim JM. PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program. Value in Health. 2025;28(6):S61. doi:10.1016/j.jval.2025.04.291
BibTeX
@article{Sikirica2025,
author = {Sikirica, Mirko V. and Rashid, Nazia and Revankar, Ratna and Youakim, James M.},
title = {PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program},
journal = {Value in Health},
year = {2025},
volume = {28},
number = {6},
pages = {S61},
doi = {10.1016/j.jval.2025.04.291}
}
EUVIMED